MedPath

Shanghai Cell Therapy Group Co., Ltd.

Shanghai Cell Therapy Group Co., Ltd. logo
🇭🇰Hong Kong, China
Ownership
Holding, Subsidiary
Established
2013-11-29
Employees
1.1K
Market Cap
-
Website
http://www.shcell.com

Phase I/II Study of αPD1-MSLN-CAR T Cells in MSLN-positive Advanced Solid Tumors

Phase 1
Not yet recruiting
Conditions
Advanced Solid Tumor
Interventions
First Posted Date
2023-07-13
Last Posted Date
2023-07-14
Lead Sponsor
Shanghai Cell Therapy Group Co.,Ltd
Target Recruit Count
42
Registration Number
NCT05944185
Locations
🇨🇳

National Cancer Center Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China

Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors

Phase 1
Recruiting
Conditions
Colorectal Cancer
Interventions
Drug: CAR T cells
First Posted Date
2021-10-22
Last Posted Date
2023-07-17
Lead Sponsor
Shanghai Cell Therapy Group Co.,Ltd
Target Recruit Count
30
Registration Number
NCT05089266
Locations
🇨🇳

National Cancer Center Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China

αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors

Early Phase 1
Conditions
Colorectal Cancer
Ovarian Cancer
Interventions
Biological: αPD1-MSLN-CAR T cells
First Posted Date
2020-08-07
Last Posted Date
2020-08-07
Lead Sponsor
Shanghai Cell Therapy Group Co.,Ltd
Target Recruit Count
10
Registration Number
NCT04503980
Locations
🇨🇳

Shanghai Tenth people's Hospital, Shanghai, Shanghai, China

Study of Safety and Efficacy of BZ019 in (R/R) Large B-cell Lymphoma

Phase 1
Conditions
Large B-cell Lymphoma
Interventions
Biological: BZ019
First Posted Date
2020-01-31
Last Posted Date
2020-01-31
Lead Sponsor
Shanghai Cell Therapy Group Co.,Ltd
Target Recruit Count
21
Registration Number
NCT04250324
Locations
🇨🇳

Hematology Hospital, Chinese Academy of Medical Sciences, Tianjin, China

🇨🇳

Tianjin medical university cancer institute and hospital, Tianjin, China

© Copyright 2025. All Rights Reserved by MedPath